[go: up one dir, main page]

EA200601554A1 - Замещенные индол-о-глюкозиды - Google Patents

Замещенные индол-о-глюкозиды

Info

Publication number
EA200601554A1
EA200601554A1 EA200601554A EA200601554A EA200601554A1 EA 200601554 A1 EA200601554 A1 EA 200601554A1 EA 200601554 A EA200601554 A EA 200601554A EA 200601554 A EA200601554 A EA 200601554A EA 200601554 A1 EA200601554 A1 EA 200601554A1
Authority
EA
Eurasian Patent Office
Prior art keywords
glucosides
substituted indol
substituted
indol
glycosides
Prior art date
Application number
EA200601554A
Other languages
English (en)
Other versions
EA010422B1 (ru
Inventor
Мэри Пэт Биверз
Мона Пател
Филип Рибжински
Мод Урбански
Сяоянь Чжан
Original Assignee
Янссен Фармацевтика Н. В.
Танабе Сейяку Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н. В., Танабе Сейяку Ко., Лтд. filed Critical Янссен Фармацевтика Н. В.
Publication of EA200601554A1 publication Critical patent/EA200601554A1/ru
Publication of EA010422B1 publication Critical patent/EA010422B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Раскрываются замещенные индол-О-гликозиды, содержащие их композиции и способы использования таких соединений, например, для лечения диабета или синдрома X.
EA200601554A 2003-08-01 2004-07-30 Замещённые индол-о-глюкозиды EA010422B1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49152303P 2003-08-01 2003-08-01
US49153403P 2003-08-01 2003-08-01
US51915503P 2003-11-12 2003-11-12
US57975804P 2004-06-15 2004-06-15
PCT/US2004/024674 WO2005012243A2 (en) 2003-08-01 2004-07-30 Substituted indole-o-glucosides

Publications (2)

Publication Number Publication Date
EA200601554A1 true EA200601554A1 (ru) 2006-12-29
EA010422B1 EA010422B1 (ru) 2008-08-29

Family

ID=34120042

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601554A EA010422B1 (ru) 2003-08-01 2004-07-30 Замещённые индол-о-глюкозиды

Country Status (10)

Country Link
US (4) US7129220B2 (ru)
EP (1) EP1680131A4 (ru)
AR (1) AR048282A1 (ru)
AU (1) AU2004261664A1 (ru)
CA (1) CA2549025A1 (ru)
EA (1) EA010422B1 (ru)
MY (1) MY142777A (ru)
SG (1) SG130189A1 (ru)
TW (1) TW200526678A (ru)
WO (1) WO2005012243A2 (ru)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20050181A2 (en) * 2002-08-29 2006-03-31 Merck & Co. Inc. Indoles having anti-diabetic activity
RU2317288C3 (ru) * 2003-03-14 2021-03-10 Астеллас Фарма Инк. С-гликозидные производные и их соли
JP2004300102A (ja) * 2003-03-31 2004-10-28 Kissei Pharmaceut Co Ltd 縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
KR100942622B1 (ko) * 2003-08-01 2010-02-17 미쓰비시 타나베 파마 코퍼레이션 나트륨-의존성 수송체에 대해 저해 활성을 갖는 신규화합물
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
SG130189A1 (en) * 2003-08-01 2007-03-20 Janssen Pharmaceutica Nv Substituted indole-o-glucosides
US20080139484A1 (en) * 2004-09-29 2008-06-12 Kissei Pharmaceutical Co., Ltd. 1(Beta-D-Glycopyranosyl)-3-Substituted Nitrogenous Heterocyclic Compound, Medicinal Composition Containing the Same, and Medicinal Use Thereof
TW200637869A (en) 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
AR053329A1 (es) * 2005-01-31 2007-05-02 Tanabe Seiyaku Co Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
TWI365186B (en) 2005-01-31 2012-06-01 Mitsubishi Tanabe Pharma Corp Indole derivatives
EP1849795B1 (en) * 2005-02-15 2011-01-26 Kissei Pharmaceutical Co., Ltd. 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
TW200726755A (en) * 2005-07-07 2007-07-16 Astellas Pharma Inc A crystalline choline salt of an azulene derivative
FR2896159B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
TWI418556B (zh) * 2006-07-27 2013-12-11 Mitsubishi Tanabe Pharma Corp 吲哚衍生物
TWI432446B (zh) * 2006-07-27 2014-04-01 Chugai Pharmaceutical Co Ltd 稠環螺酮縮醇衍生物、及其做為糖尿病治療藥之使用
ES2452343T3 (es) 2006-09-29 2014-04-01 Glaxosmithkline Llc Compuestos de indol sustituidos
TWI499414B (zh) 2006-09-29 2015-09-11 Lexicon Pharmaceuticals Inc 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
JP5298025B2 (ja) * 2006-12-04 2013-09-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗糖尿病薬としてのチエニル含有グリコピラノシル誘導体
CN101568537A (zh) * 2006-12-21 2009-10-28 安斯泰来制药有限公司 C-糖苷衍生物的制造方法及其合成中间体
EP2106260B8 (en) 2007-01-25 2018-04-04 Naia Metabolic, Inc. Insulin sensitisers and methods of treatment
US7846945B2 (en) 2007-03-08 2010-12-07 Lexicon Pharmaceuticals, Inc. Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use
EP2200606B1 (en) 2007-09-10 2017-10-25 Janssen Pharmaceutica, N.V. Process for the preparation of compounds useful as inhibitors of sglt
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
GB0900864D0 (en) 2009-01-19 2009-03-04 Syngenta Ltd Novel Herbicides
US20110009347A1 (en) * 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
JP5658751B2 (ja) 2009-07-10 2015-01-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ １−（β−Ｄ−グルコピラノシル）−４−メチル−３−［５−（４−フルオロフェニル）−２−チエニルメチル］ベンゼンのための結晶化方法
NZ599306A (en) * 2009-10-14 2014-06-27 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
PT2496583E (pt) 2009-11-02 2015-01-14 Pfizer Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
CN102134226B (zh) * 2010-01-26 2013-06-12 天津药物研究院 一类苯基c-葡萄糖苷衍生物、其制备方法和用途
WO2011107494A1 (de) * 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
CA2799204C (en) 2010-05-11 2018-11-06 Janssen Pharmaceutica Nv Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
CA2832938C (en) 2011-04-13 2019-09-03 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
US9035044B2 (en) 2011-05-09 2015-05-19 Janssen Pharmaceutica Nv L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US20150174108A1 (en) 2012-05-24 2015-06-25 Vera Pharmaceuticals Ltd Method of weight reduction
MX362111B (es) 2012-05-24 2019-01-07 Verva Pharmaceuticals Ltd Un metodo para mejorar la funcion hepatica.
GB201310047D0 (en) 2013-06-05 2013-07-17 Syngenta Ltd Compounds
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
US20240358735A1 (en) * 2021-08-27 2024-10-31 Boyce Thompson Institute For Plant Research, Inc. Therapeutic compositions and related methods
CN118290500B (zh) * 2024-04-10 2025-05-02 辽宁中医药大学 马齿苋中一种新吡啶类生物碱化合物及提取分离方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584369A (en) 1981-07-31 1986-04-22 Sloan-Kettering Institute For Cancer Research Anti-leukemic beta-glycosyl C-nucleosides
US5334225A (en) 1992-07-15 1994-08-02 Kao Corporation Keratinous fiber dye composition containing a 2-substituted amino-5-alkylphenol derivative coupler
CA2102591C (en) 1992-11-12 2000-12-26 Kenji Tsujihara Hypoglycemic agent
US5731292A (en) 1992-11-12 1998-03-24 Tanabe Seiyaku Co., Ltd. Dihydrochalcone derivatives which are hypoglycemic agents
US6297363B1 (en) * 1993-02-12 2001-10-02 Nomura Co., Ltd. Glycoside indoles
US5830873A (en) 1994-05-11 1998-11-03 Tanabe Seiyaku Co., Ltd. Propiophenone derivative and a process for preparing the same
JPH07320652A (ja) * 1994-05-27 1995-12-08 Toshiba Corp カラー受像管及びシャドウマスクの製造方法
US5780483A (en) 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
JP3059088B2 (ja) 1995-11-07 2000-07-04 田辺製薬株式会社 プロピオフェノン誘導体およびその製法
TW406086B (en) 1996-12-26 2000-09-21 Tanabe Seiyaku Co Propiophenone derivatives and process for preparing the same
US6153632A (en) 1997-02-24 2000-11-28 Rieveley; Robert B. Method and composition for the treatment of diabetes
US6515003B1 (en) 1999-08-31 2003-02-04 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of diabetes and other diseases
US6515117B2 (en) 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
PH12000002657B1 (en) 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
US6627611B2 (en) 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents
CN1177857C (zh) 2000-03-17 2004-12-01 橘生药品工业株式会社 吡喃葡萄糖氧基苄基苯衍生物、包含该物质的药用组合物及制备该衍生物用的中间体
US6555519B2 (en) 2000-03-30 2003-04-29 Bristol-Myers Squibb Company O-glucosylated benzamide SGLT2 inhibitors and method
US6683056B2 (en) 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
US6936590B2 (en) 2001-03-13 2005-08-30 Bristol Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
ES2258141T3 (es) 2001-04-11 2006-08-16 Bristol-Myers Squibb Company Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento.
US7001743B2 (en) 2001-04-19 2006-02-21 The Penn State Research Foundation Expansin polynucleotides, related polypeptides and methods of use
JP4399251B2 (ja) 2001-05-30 2010-01-13 キッセイ薬品工業株式会社 グルコピラノシルオキシピラゾール誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体
GB0113232D0 (en) 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical process
BR0210510A (pt) 2001-06-20 2005-01-11 Kissei Pharmaceutical Derivado heterocìclico contendo nitrogênio, composição medicinal contendo o mesmo, uso médico do mesmo e intermediário para o mesmo
WO2003011880A1 (fr) 2001-07-31 2003-02-13 Kissei Pharmaceutical Co., Ltd. Derive de glucopyranosyloxybenzylbenzene, composition medicinale contenant ce derive, usage medicinal de cette composition et produit intermediaire pour produire cette composition
US20030087843A1 (en) 2001-09-05 2003-05-08 Washburn William N. O-pyrazole glucoside SGLT2 inhibitors and method of use
US7384763B2 (en) * 2001-10-24 2008-06-10 Michael Burton Method of detecting β-D-ribofuranosidase activity
DE60212683T2 (de) 2001-11-16 2007-06-28 Cutanix Corp., Los Altos Pharmazeutische und kosmetische zusammensetzungen mit oxy-gruppen-tragenden aromatischen aldehyden
US6617313B1 (en) 2002-03-13 2003-09-09 Council Of Scientific And Industrial Research Glucopyranoside and process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof
US6562791B1 (en) 2002-03-29 2003-05-13 Council Of Scientific And Industrial Research Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
JP4309769B2 (ja) 2002-04-08 2009-08-05 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ 新規なグルコピラノサイド、その分離方法、それを含む薬物及びその使用方法
RU2317288C3 (ru) 2003-03-14 2021-03-10 Астеллас Фарма Инк. С-гликозидные производные и их соли
JP2004300102A (ja) 2003-03-31 2004-10-28 Kissei Pharmaceut Co Ltd 縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
SG130189A1 (en) * 2003-08-01 2007-03-20 Janssen Pharmaceutica Nv Substituted indole-o-glucosides

Also Published As

Publication number Publication date
EP1680131A2 (en) 2006-07-19
US20050037981A1 (en) 2005-02-17
US20060293251A1 (en) 2006-12-28
CA2549025A1 (en) 2005-02-10
SG130189A1 (en) 2007-03-20
WO2005012243A2 (en) 2005-02-10
US7129220B2 (en) 2006-10-31
US20100009900A1 (en) 2010-01-14
US7820630B2 (en) 2010-10-26
EP1680131A4 (en) 2009-05-27
AR048282A1 (es) 2006-04-19
WO2005012243A3 (en) 2005-08-11
US20090105164A1 (en) 2009-04-23
TW200526678A (en) 2005-08-16
AU2004261664A1 (en) 2005-02-10
US7511022B2 (en) 2009-03-31
MY142777A (en) 2010-12-31
EA010422B1 (ru) 2008-08-29

Similar Documents

Publication Publication Date Title
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
UA86042C2 (en) Substituted indazole-o-glucosides
EA200700225A1 (ru) Аналоги тетрапептида
ATE433447T1 (de) Pyrimiidinverbindungen
SE0301700D0 (sv) Novel compounds
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
SE0302139D0 (sv) Novel compounds
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
CY1105345T1 (el) Φαινυλαλκινια
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
DE60228295D1 (de) Chemische verbindungen
TW200503672A (en) 2-aminobenzoyl derivatives
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
RS20060323A (en) Substituted indole-o-glucosides
DK1366033T3 (da) Kemiske forbindelser
RS20060322A (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU